WEKO3
アイテム
Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma
http://hdl.handle.net/10271/00003673
http://hdl.handle.net/10271/000036732e088722-027e-4b61-b49d-efbbc837500a
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
|
Item type | 学位論文 / Thesis or Dissertation(1) | |||||||
---|---|---|---|---|---|---|---|---|
公開日 | 2019-12-06 | |||||||
タイトル | ||||||||
タイトル | Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma | |||||||
言語 | en | |||||||
言語 | ||||||||
言語 | eng | |||||||
資源タイプ | ||||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_db06 | |||||||
資源タイプ | doctoral thesis | |||||||
アクセス権 | ||||||||
アクセス権 | open access | |||||||
アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||||
その他のタイトル | ||||||||
その他のタイトル | 膵管がんおける選択されたテトラヌクレオチドリピートにおけるマイクロサテライト変化の上昇状態の頻度 | |||||||
著者 |
森, 泰希
× 森, 泰希
|
|||||||
書誌情報 |
en : PloS one 巻 13, 号 12, p. e0208557, 発行日 2018-12-07 |
|||||||
出版者 | ||||||||
出版者 | PLoS (Public Library of Science) | |||||||
言語 | en | |||||||
抄録 | ||||||||
内容記述タイプ | Abstract | |||||||
内容記述 | Pancreatic ductal adenocarcinoma (PDAC) prognosis remains poor even after complete resection owing to no valuable biomarkers for recurrence and chemosensitivity. Tumors not expressing MSH3 show elevated microsatellite alterations at selected tetranucleotide repeats (EMAST). EMAST reportedly occurs in several tumors. In colorectal cancer (CRC), EMAST was reportedly correlated with 5-fluorouracil (5-FU) sensitivity. However, EMAST prevalence in PDAC and its significance as a prognostic biomarker are unknown. This study aimed to investigate EMAST prevalence in PDAC and the associations between EMAST and pathological factors, EMAST and prognosis, and EMAST and MSH3 expression via immunohistochemistry (IHC). We assessed 40 PDAC patients undergoing surgery. Genomic DNA was extracted from tumors and normal tissues. EMAST and microsatellite instability- high (MSI-H) were analyzed using five polymorphic tetranucleotide markers and five mononucleotide markers, respectively. Tumor sections were stained for MSH3, and staining intensity was evaluated via the Histoscore (H-score). Eighteen of 40 (45%) PDAC patients were EMAST-positive; however, none were MSI-H-positive. Clinicopathological characteristics including overall survival (OS) and recurrence-free survival (RFS) were not significantly different between EMAST-positive and EMAST-negative patients (P = 0.45, 0.98 respectively). IHC was performed to evaluate MSH3 protein expression levels for the PDAC tissue specimens. H-scores of EMAST-positive patients ranged from 0 to 300 (median, 40) and those of EMAST-negative patients ranged from 0 to 300 (median, 170). MSH3 protein was not significantly downregulated in EMAST-positive patients (P = 0.07). This study is a preliminary study and the number of cases investigated was small, and thus, study of a larger cohort will reveal the clinical implication of EMAST. | |||||||
言語 | en | |||||||
学位名 | ||||||||
学位名 | 博士(医学) | |||||||
学位の区分 | ||||||||
内容記述 | doctoral | |||||||
学位の分野 | ||||||||
内容記述 | 医学系研究科 | |||||||
学位授与機関 | ||||||||
学位授与機関識別子Scheme | kakenhi | |||||||
学位授与機関識別子 | 13802 | |||||||
学位授与機関名 | 浜松医科大学 | |||||||
学位授与年月日 | ||||||||
学位授与年月日 | 2019-03-13 | |||||||
学位授与番号 | ||||||||
学位授与番号 | 甲第814号 | |||||||
EISSN | ||||||||
収録物識別子タイプ | EISSN | |||||||
収録物識別子 | 1932-6203 | |||||||
PubMed番号 | ||||||||
識別子タイプ | PMID | |||||||
関連識別子 | 30532127 | |||||||
出版社DOI | ||||||||
識別子タイプ | DOI | |||||||
関連識別子 | https://doi.org/10.1371/journal.pone.0208557 | |||||||
著者版フラグ | ||||||||
出版タイプ | VoR | |||||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 |